MedTrace Logo

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

NCT06295367 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 760

Last updated 2026-05-15

No results posted yet for this study

Summary

This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, income and insurance. Financial hardship can lead to a delay or a stop in cancer care, and is linked to poor quality of life. Financial navigation programs, such as CostCOM, provide financial counseling, education and connections to appropriate resources to reduce financial barriers to healthcare and minimize financial stress and burden. CostCOM may improve adherence to care and decrease financial burden in patients with cancer.

Conditions

  • Malignant Solid Neoplasm

Interventions

OTHER

Best Practice

Receive PAF brochure describing financial navigation services

OTHER

Financial Navigation

Receive CostCOM financial counseling

OTHER

Interview

Participate in a 1 on 1 in-depth interview

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Gelareh Sadigh · ECOG-ACRIN Cancer Research Group

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2027-12-01
Completion
2027-12-01

Countries

  • United States
  • Guam
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06295367 on ClinicalTrials.gov